US Patent 9963504 Anti-CXCL13 antibodies and methods of using the same
Patent 9963504 was granted and assigned to Vaccinex, Inc on May, 2018 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
September 1, 2011
Date of Patent
May 8, 2018
Patent Application Number
13820278
Patent Citations Received
Patent Inventor Names
Mark Paris
0
Ernest S. Smith
0
Ekaterina Klimatcheva
0
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 9963504 Anti-CXCL13 antibodies and methods of using the same
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.